EP1811986
GABAPENTIN PRODRUG SUSTAINED RELEASE ORAL DOSAGE FORMS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.11.2005EP published:
26.3.2014EP application number:
05826200.7
EPO information:
European Patent Register
Max expiry date:
2.11.2025
Title:
GABAPENTIN PRODRUG SUSTAINED RELEASE ORAL DOSAGE FORMS
Timeline
Today
3.11.2005EP application
26.3.2014EP Publication
Owner
Name:
XenoPort, Inc.Address:
3410 Central Expressway, 95051, Santa Clara, CA, US
Inventor
Name:
CUNDY, Kenneth, C.Address:
Redwood City, CA, US
Name:
SASTRY, SrikondaAddress:
Sunnyvale, California, US
Name:
LEUNG, ManshiuAddress:
Daly City, CA, US
Name:
KADRI, Balaji, V.Address:
Tampa, FL, US
Name:
STACH, Paul, E.Address:
Plymouth, Minnesota, US
Priority
Number:
625737 PDate:
4.11.2004Country:
US
Classification
Categories:
A61K 31/225, A61K 9/20, A61K 31/197